Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus

Jason W. Bennett*, Clinton K. Murray, Robert L. Holmes, Jan E. Patterson, James H. Jorgensen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

An elderly patient with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was treated sequentially with vancomycin plus rifampin then daptomycin plus gentamicin. The MRSA strain developed diminished susceptibility to vancomycin (MIC increase and tolerance), daptomycin, and gentamicin, and resistance to rifampin during therapy.

Original languageEnglish
Pages (from-to)437-440
Number of pages4
JournalDiagnostic Microbiology and Infectious Disease
Volume60
Issue number4
DOIs
StatePublished - Apr 2008
Externally publishedYes

Keywords

  • Bactericidal effect
  • Daptomycin resistance
  • MRSA bacteremia
  • Minimum inhibitory concentration
  • Vancomycin tolerance

Fingerprint

Dive into the research topics of 'Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus'. Together they form a unique fingerprint.

Cite this